Pharmaceutical
Ended Awarded Last action
- Contract number
- 36C26024F0173
- Awardee
-
Vanda Pharmaceuticals Inc. UEI NG5JU1TQ3379
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $154,049
Award facts
- Contract value 100% obligated
- $154,048.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$8,722 | |
| Other Administrative Action | $0 | |
| Original award | $162,771 |
About this award
This is a federal contract award to Vanda Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, by the U.S. Department of Veterans Affairs (VA). The contract, which is not set aside, is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a ceiling value of $154,048.79 and a performance period through December 31, 2024.
Vanda Pharmaceuticals is the sole manufacturer of HETLIOZ (tasimelteon), a specialized medication used to treat Non-24-Hour Sleep-Wake Disorder in blind adults and patients with Smith-Magenis Syndrome. This contract supports the VA's efforts to provide this specialized medication to eligible veterans through its regional Veterans Integrated Service Networks (VISNs). Vanda has been awarded multiple delivery order contracts under the FSS-61-IB schedule, as well as two significant Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, to ensure the consistent availability of HETLIOZ for veterans with specific sleep disorders.
Quick answers
Who was awarded contract 36C26024F0173?
36C26024F0173 was awarded to Vanda Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 1, 2024.
How much is contract 36C26024F0173 worth?
The government has obligated $154,049 on 36C26024F0173.
Is contract 36C26024F0173 an order under another contract?
Yes. 36C26024F0173 is a delivery order under V797D70102, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0173 competed?
The extent of competition for 36C26024F0173 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award